InsiderTrades.com logo
He Is Giving Away Bitcoin
From Crypto Swap Profits   |   Ad
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
>> Register right here
Aaron VanDevender net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Aaron VanDevender Biography and Net Worth

Director of Applied Molecular Transport
Dr. VanDevender joined our board of directors in November 2016. Since February 2020, Dr. VanDevender has served as Chief Scientific Consultant at Founders Fund, LLC, a venture capital firm and from November 2012 to February 2020, Dr. VanDevender served as Chief Scientist and Principal at Founders Fund, LLC. From October 2010 to March 2012, Dr. VanDevender served as a physicist at Halcyon Molecular, Inc., a company focused on DNA sequencing technology. From October 2007 to September 2010, he worked as a physicist at the National Institute of Standards and Technology. Dr. VanDevender holds a BS in Physics from the Massachusetts Institute of Technology and a PhD in Physics from the University of Illinois, Urbana-Champaign.

What is Aaron VanDevender's net worth?

The estimated net worth of Aaron VanDevender is at least $55,929.32 as of November 28th, 2022. Mr. VanDevender owns 212,659 shares of Applied Molecular Transport stock worth more than $55,929 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. VanDevender may own. Learn More about Aaron VanDevender's net worth.

How do I contact Aaron VanDevender?

The corporate mailing address for Mr. VanDevender and other Applied Molecular Transport executives is 1 TOWER PLACE SUITE 850, SOUTH SAN FRANCISCO CA, 94080. Applied Molecular Transport can also be reached via phone at 650-392-0420 and via email at [email protected]. Learn More on Aaron VanDevender's contact information.

Has Aaron VanDevender been buying or selling shares of Applied Molecular Transport?

Aaron VanDevender has not been actively trading shares of Applied Molecular Transport during the last quarter. Most recently, on Monday, November 28th, Aaron Vandevender bought 50,000 shares of Applied Molecular Transport stock. The stock was acquired at an average cost of $1.00 per share, with a total value of $50,000.00. Following the completion of the transaction, the director now directly owns 212,659 shares of the company's stock, valued at $212,659. Learn More on Aaron VanDevender's trading history.

Who are Applied Molecular Transport's active insiders?

Applied Molecular Transport's insider roster includes Elizabeth Bhatt (Insider), Shawn Cross (CFO), Bittoo Kanwar (Insider), Helen Kim (Director), David Lamond (Director), Tahir Mahmood (CEO), Randall Mrsny (Insider), and Aaron VanDevender (Director). Learn More on Applied Molecular Transport's active insiders.

Are insiders buying or selling shares of Applied Molecular Transport?

During the last twelve months, insiders at the sold shares 14 times. They sold a total of 1,097,868 shares worth more than $176,549.76. The most recent insider tranaction occured on November, 22nd when CEO Shawn Cross sold 110,802 shares worth more than $17,728.32. Insiders at Applied Molecular Transport own 15.9% of the company. Learn More about insider trades at Applied Molecular Transport.

Information on this page was last updated on 11/22/2023.

Aaron VanDevender Insider Trading History at Applied Molecular Transport

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/28/2022Buy50,000$1.00$50,000.00212,659View SEC Filing Icon  
11/25/2022Buy100,000$1.00$100,000.00162,659View SEC Filing Icon  
2/28/2022Buy4,112$6.51$26,769.12View SEC Filing Icon  
See Full Table

Aaron VanDevender Buying and Selling Activity at Applied Molecular Transport

This chart shows Aaron Vandevender's buying and selling at Applied Molecular Transport by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Applied Molecular Transport Company Overview

Applied Molecular Transport logo
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc.
Read More

Today's Range

Now: $0.26
Low: $0.26
High: $0.26

50 Day Range

MA: $0.24
Low: $0.16
High: $0.31

2 Week Range

Now: $0.26
Low: $0.13
High: $0.84

Volume

N/A

Average Volume

470,969 shs

Market Capitalization

$10.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.28
He Is Giving Away Bitcoin
From Crypto Swap Profits   |   Ad
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
>> Register right here